Related Experiment Video
Updated: May 8, 2026

Fluorescence Recovery After Photobleaching FRAP of Fluorescence Tagged Proteins in Dendritic Spines of Cultured Hippocampal Neurons
Published on: April 16, 2011
Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond
David Calvin Goff1, Sadiya Sana Khan2, Donald Lloyd-Jones2
1Division of Cardiovascular Sciences (D.C.G., G.S.W.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Insights
Coronary heart disease mortality decline may be reversing, with heart failure deaths rising. A symposium reviewed progress since 1978 and discussed strategies to improve cardiovascular health.
Area of Science:
- Cardiovascular Disease Epidemiology
- Public Health Policy
- Preventive Cardiology
Background:
- The 1978 Bethesda Conference provided a framework for understanding declining coronary heart disease (CHD) mortality.
- Recent trends suggest CHD mortality decline has stalled or reversed, with increasing heart failure (HF) mortality.
- Advances in knowledge and treatment have not fully halted adverse cardiovascular disease (CVD) trends.
Purpose of the Study:
- To commemorate the 40th anniversary of the 1978 Bethesda Conference.
- To evaluate the outcomes of the 1978 conference and assess the current CVD landscape.
- To identify opportunities for preserving and promoting cardiovascular health and preventing CVD.
Main Methods:
- Convened the "Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40" symposium.
- Discussed trends and projections in CVD, obesity, and diabetes.
- Explored challenges and barriers to promoting cardiovascular health across the lifespan.
Main Results:
- Overall CVD mortality rates are decelerating, but HF mortality is increasing.
- Emerging epidemics of obesity and diabetes pose significant challenges.
- A framework for early-life interventions and observational research was proposed.
Conclusions:
- The trajectory of cardiovascular disease mortality is complex and requires renewed focus.
- Interventions targeting early life, including in utero, are crucial for long-term cardiovascular health.
- Addressing obesity and diabetes is essential for preventing future CVD.
Abstract:
More than 40 years after the 1978 Bethesda Conference on the Declining Mortality from Coronary Heart Disease provided the scientific community with a blueprint for systematic analysis to understand declining rates of coronary heart disease, there are indications the decline has ended or even reversed despite advances in our knowledge about the condition and treatment. Recent data show a more complex situation, with mortality rates for overall cardiovascular disease, including coronary heart disease and stroke, decelerating, whereas those for heart failure are increasing. To mark the 40th anniversary of the Bethesda Conference, the National Heart, Lung, and Blood Institute and the American Heart Association cosponsored the "Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40" symposium. The objective was to examine the immediate and long-term outcomes of the 1978 conference and understand the current environment. Symposium themes included trends and future projections in cardiovascular disease (in the United States and internationally), the evolving obesity and diabetes epidemics, and harnessing emerging and innovative opportunities to preserve and promote cardiovascular health and prevent cardiovascular disease. In addition, participant-led discussion explored the challenges and barriers in promoting cardiovascular health across the lifespan and established a potential framework for observational research and interventions that would begin in early childhood (or ideally in utero). This report summarizes the relevant research, policy, and practice opportunities discussed at the symposium.
Related Concept Videos
Bias in Epidemiological Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management

